Selection Committee

Selection Committee



Comprises domestic and international experts with extensive knowledge and experience in research and development of drugs, vaccines, and diagnostics. The Selection Committee is the key decision-making body in reviewing applications and awarding investments in this area. This committee evaluates investment proposals and reports from development partners, and recommends investments to the Board of Directors.

Chairman

Paul Herrling

Former Head of Corporate Research at Novartis and the Chairman of the Board of the Novartis Institute for Tropical Diseases

Member

Ann Mills-Duggan

Partner, Innovations, Wellcome Trust

Member

Melissa Malhame

Principal, MM Global Health Consulting LLC

Member

Insoo Kim

CEO/Founder, Eupidia Co., Ltd
Adjunct Professor, Sogang University

Member

Christian Lienhardt

Research Director, French National Research Institute for Development (IRD, Institut de Recherche pour le Développement)

Member

Gerald Voss

Executive Director
SciPeo Sprl, Science and People

Ex-officio

Dan Wattendorf

Director of Innovative Technology Solutions, Bill and Melinda Gates Foundation

Member

Joon Haeng Rhee

Professor of Microbiology, Chonnam National University Medical School